Business
Establishment Labs Reports First Quarter 2025 Financial Results
NEW YORK--(BUSINESS WIRE)-- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and
About this update from Establishment Labs Holdings Inc.
[{"type":"text","content":" NEW YORK--(BUSINESS WIRE)--\nEstablishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced financial results for the first quarter ended March 31, 2025.\n\nFirst Quarter Highlights and Outlook\n\n\nFirst quarter worldwide revenue of $41.4 million, including $6.2 million of Motiva sales in the United States.\n\n\n2025 revenue guidance maintained at $205 million to $210 million, year over year growth of 23%–26%.\n\n\nFirst quarter gross margin of 67.2% compared to 65.6% in the year-ago period.\n\n\nFirst quarter loss from operations was $16.9 million compared to a loss of $8.8 million in the year-ago period.\n\n\nFirst quarter adjusted EBITDA loss of $12.1 million compared to a loss of $4.0 million in the year-ago period.\n\n\nFirst quarter cash use before financing was $21.0 million compared to use of $18.1 million in the year ago period.\n\n\nCash balance of $69.2 million as of March 31, 2025.\n\n\nPeter Caldini appointed CEO effective May 7, 2025.\n\n\nLaunched Preservé, the second offering in the company’s minimally invasive platform.\n\n\n“Our Motiva launch in the United States continues to be one of the fastest aesthetic launches in history,” said Peter Caldini, Chief Executive Officer. “Our momentum is increasing, and our success in the United States is having a positive impact on our overall results. We should meaningfully exceed the $35 million US revenue guidance we provided in February and are on track to achieve positive EBITDA in 2025 and cash flow positive in 2026. As we continue to scale our business, improve execution, and find additional cost efficiencies globally, these improvements will be clear in our results.”\n\nFirst Quarter 2025 Financial Results\n\nTotal revenue for the quarter ended March 31, 2025 was $41.4 million compared to $37.2 million for the same period in 2024.\n\nGross profit for the first quarter was $27.8 million, or 67.2% of revenue, compared to $24.4 million, or 65.6% of revenue, for the same period in 2024. The increase in gross profit margin was primarily driven by geographic mix and higher average selling prices.\n\nTotal operating expenses for the first quarter were $44.8 million, a increase of $11.6 million compared to $33.2 million in the first...